These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30057295)

  • 21. Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safety.
    Bombardier C; Hazlewood GS; Akhavan P; Schieir O; Dooley A; Haraoui B; Khraishi M; Leclercq SA; Légaré J; Mosher DP; Pencharz J; Pope JE; Thomson J; Thorne C; Zummer M; Gardam MA; Askling J; Bykerk V;
    J Rheumatol; 2012 Aug; 39(8):1583-602. PubMed ID: 22707613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of glucocorticoids on bone mineral density in patients with rheumatoid arthritis: A systematic review and meta-analysis of randomized, controlled trials.
    Blavnsfeldt AG; de Thurah A; Thomsen MD; Tarp S; Langdahl B; Hauge EM
    Bone; 2018 Sep; 114():172-180. PubMed ID: 29913256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of patients with rheumatoid arthritis in Latin America: a consensus position paper from Pan-American League of Associations of Rheumatology and Grupo Latino Americano De Estudio De Artritis Reumatoide.
    Massardo L; Suárez-Almazor ME; Cardiel MH; Nava A; Levy RA; Laurindo I; Soriano ER; Acevedo-Vázquez E; Millán A; Pineda-Villaseñor C; Galarza-Maldonado C; Caballero-Uribe CV; Espinosa-Morales R; Pons-Estel BA
    J Clin Rheumatol; 2009 Jun; 15(4):203-10. PubMed ID: 19502907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocorticoids in the treatment of rheumatoid arthritis: still used after 65 years.
    Bijlsma JW; Jacobs JW
    Ann N Y Acad Sci; 2014 May; 1318():27-31. PubMed ID: 24641732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial.
    Burmester GR; Buttgereit F; Bernasconi C; Álvaro-Gracia JM; Castro N; Dougados M; Gabay C; van Laar JM; Nebesky JM; Pethoe-Schramm A; Salvarani C; Donath MY; John MR;
    Lancet; 2020 Jul; 396(10246):267-276. PubMed ID: 32711802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
    Ruiz Garcia V; Burls A; Cabello JB; Vela Casasempere P; Bort-Marti S; Bernal JA
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007649. PubMed ID: 28884785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penicillamine for rheumatoid arthritis.
    Suarez-Almazor ME; Spooner C; Belseck E
    Cochrane Database Syst Rev; 2000; 2000(2):CD001460. PubMed ID: 10796440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons.
    Graudal N; Jürgens G
    Arthritis Rheum; 2010 Oct; 62(10):2852-63. PubMed ID: 20560138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severity indices in rheumatoid arthritis: A systematic review.
    Toledano E; García de Yébenes MJ; González-Álvaro I; Carmona L
    Reumatol Clin (Engl Ed); 2019; 15(3):146-151. PubMed ID: 28807652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treating to target in established rheumatoid arthritis: Challenges and opportunities in an era of novel targeted therapies and biosimilars.
    Woodworth TG; den Broeder AA
    Best Pract Res Clin Rheumatol; 2015; 29(4-5):543-9. PubMed ID: 26697765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What do we know about the safety of corticosteroids in rheumatoid arthritis?
    Ethgen O; de Lemos Esteves F; Bruyere O; Reginster JY
    Curr Med Res Opin; 2013 Sep; 29(9):1147-60. PubMed ID: 23790244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Rituximab in rheumatoid arthritis: a systematic review of efficacy and safety].
    Hernández-Cruz B; García-Arias M; Ariza Ariza R; Martín Mola E
    Reumatol Clin; 2011; 7(5):314-22. PubMed ID: 21925447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023.
    Abud-Mendoza C; Aceves-Ávila FJ; Arce-Salinas CA; Álvarez Nemegyei J; Barile-Fabris L; Durán-Barragán S; Flores-Alvarado DE; Hernández-Núñez E; Irazoque-Palazuelos F; Moctezuma-Ríos JF; Pascual-Ramos V; Portela-Hernández M; Silveira LH; Andrade-Ortega L; Barrera-Vargas A; Carrillo-Vázquez S; Castro-Colin Z; Cuevas-Orta E; Flores-Suárez LF; Guaracha-Basáñez GA; Hernández-Cabrera MF; de Jesús Hernández-Galarza I; Herrera-vanOostdam DA; Lobato-Belmonte AC; Martínez-Martínez LA; Martínez-Martínez MU; Medrano-Ramírez G; Merayo-Chalico FJ; Meza-López Y Olguín G; Olan F; Peña-Santos G; Ramos-Remus C; Reyes-Cordero G; Rivera-Terán V; Rojas-Serrano J; Serna-Peña G; Sicsik-Ayala S; Sifuentes-Cantú CA; Vega-Morales D; Villaseñor-Ovies P; Xibillé-Friedmann D; Pacheco-Tena C
    Reumatol Clin (Engl Ed); 2024 May; 20(5):263-280. PubMed ID: 38796394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.
    Bykerk VP; Akhavan P; Hazlewood GS; Schieir O; Dooley A; Haraoui B; Khraishi M; Leclercq SA; Légaré J; Mosher DP; Pencharz J; Pope JE; Thomson J; Thorne C; Zummer M; Bombardier C;
    J Rheumatol; 2012 Aug; 39(8):1559-82. PubMed ID: 21921096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
    Smolen JS; Landewé RBM; Bijlsma JWJ; Burmester GR; Dougados M; Kerschbaumer A; McInnes IB; Sepriano A; van Vollenhoven RF; de Wit M; Aletaha D; Aringer M; Askling J; Balsa A; Boers M; den Broeder AA; Buch MH; Buttgereit F; Caporali R; Cardiel MH; De Cock D; Codreanu C; Cutolo M; Edwards CJ; van Eijk-Hustings Y; Emery P; Finckh A; Gossec L; Gottenberg JE; Hetland ML; Huizinga TWJ; Koloumas M; Li Z; Mariette X; Müller-Ladner U; Mysler EF; da Silva JAP; Poór G; Pope JE; Rubbert-Roth A; Ruyssen-Witrand A; Saag KG; Strangfeld A; Takeuchi T; Voshaar M; Westhovens R; van der Heijde D
    Ann Rheum Dis; 2020 Jun; 79(6):685-699. PubMed ID: 31969328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy and safety of antidepressants in inflammatory arthritis: a Cochrane systematic review.
    Richards BL; Whittle SL; van der Heijde DM; Buchbinder R
    J Rheumatol Suppl; 2012 Sep; 90():21-7. PubMed ID: 22942325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term and long-term safety of glucocorticoids in rheumatoid arthritis.
    Saag KG
    Bull NYU Hosp Jt Dis; 2012; 70 Suppl 1():21-5. PubMed ID: 23259654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
    Colebatch AN; Marks JL; Edwards CJ
    Cochrane Database Syst Rev; 2011 Nov; (11):CD008872. PubMed ID: 22071858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
    Ramiro S; Radner H; van der Heijde D; van Tubergen A; Buchbinder R; Aletaha D; Landewé RB
    Cochrane Database Syst Rev; 2011 Oct; (10):CD008886. PubMed ID: 21975788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral low-dose glucocorticoids should be included in any recommendation for the use of non-biologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis.
    Caporali R; Todoerti M; Scirè CA; Montecucco C; Cutolo M
    Neuroimmunomodulation; 2015; 22(1-2):104-11. PubMed ID: 25227117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.